三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图表16巴替利单抗+泽弗利单抗宫颈癌数据及与已上市疗法数据对比
图表16巴替利单抗+泽弗利单抗宫颈癌数据及与已上市疗法数据对比
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:473KB
图片尺寸:1801*717
同报告图片
/
4
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
所属报告:
医药生物行业跟踪报告:创新药系列研究L1普药化国内IO市场如何演绎-210902(21页).pdf
打包全文图表
相关数据
ZG005治疗宫颈癌患者的无进展生存期(IRC评估)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
图 3.5. 2019年近五分之三的女性接受了宫颈癌筛查,接近OECD平均水平
收藏
行业数据
2026-04-01
原图定位
查看详情
图3-19重庆市2020~2024年宫颈癌项目癌及癌前病变检出率变化趋势
fCDlubTku70gICB8IOajgOWHuueOh++8iDEvMTDkuIfvvIkgfAp8LS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMjDlubQgfCA0MDAuMjUgICAgICAgICAgIHwKfCAyMDIx5bm0IHwgNTIyLjk3ICAgICAgICAgICB8CnwgMjAyMuW5tCB8IDU0My40NyAgICAgICAgICAgfAp8IDIwMjPlubQgfCA1MzAuOTkgICAgICAgICAgIHwKfCAyMDI05bm0IHwgNDczLjY4ICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlm74zLTE5IOmHjeW6huW4gjIwMjDvvZ4yMDI05bm05a6r6aKI55mM6aG555uu55mM5Y+K55mM5YmN55eF5Y+Y5qOA5Ye6546H5Y+Y5YyW6LaL5Yq/
收藏
行业数据
2025-11-11
原图定位
查看详情
图3-20 重庆市2020~2024年宫颈癌项目早诊率变化趋势
fCDlubTku70gICB8IOaXqeiviueOh++8iCXvvIkgfAp8LS0tLS0tLS18LS0tLS0tLS0tLS0tLXwKfCAyMDIw5bm0IHwgOTQuMjYgICAgICAgfAp8IDIwMjHlubQgfCA5My43NyAgICAgICB8CnwgMjAyMuW5tCB8IDkzLjY5ICAgICAgIHwKfCAyMDIz5bm0IHwgOTQuMzYgICAgICAgfAp8IDIwMjTlubQgfCA5NC4xNSAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlm74zLTIwIOmHjeW6huW4gjIwMjDvvZ4yMDI05bm05a6r6aKI55mM6aG555uu5pep6K+K546H5Y+Y5YyW6LaL5Yq/
收藏
行业数据
2025-11-11
原图定位
查看详情
全球首个FGFR4抑制剂联合IO在HCC的临床设计:依帕戈替尼联合阿替利珠单抗的临床二期试验方案
PHxiZWdpbl9vZl9ib3h8PnwgUGFydCB8IERvc2UgUmVnaW1lbiAgICAgICB8IFNhbXBsZSBTaXplIChOKSB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS18CnwgQSAgICB8IDE4MG1nIFFEICAgICAgICAgICB8IDYgICAgICAgICAgICAgICB8CnwgQSAgICB8IDMyMG1nIFFEICAgICAgICAgICB8IDYgICAgICAgICAgICAgICB8CnwgQSAgICB8IDE2MG1nIEJJRCAgICAgICAgICB8IDggICAgICAgICAgICAgICB8CnwgQSAgICB8IDIyMG1nIEJJRCAgICAgICAgICB8IDMzICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7hQUFQ8fGVuZF9vZl9ib3h8Pg==
收藏
行业数据
2025-10-10
原图定位
查看详情
2025版NCCN宫颈癌治疗指南
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
收藏
行业数据
2025-09-24
原图定位
查看详情
Bosakitug与特泽利尤单抗治疗特应性皮炎的疗效对比
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
收藏
行业数据
2025-08-01
原图定位
查看详情
特泽利尤单抗全球销售额
fCDlubTku70gfCDnibnms73liKnlsKTljZXmipflhajnkIPplIDllK7pop3vvIjnmb7kuIfnvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMjIgfCAxNzQgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjMgfCA2NTMgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjQgfCAxLDIyMCAgICAgICAgICAgICAgICAgICAgICAgfAoKCui1hOaWmeadpea6kO+8muWFrOWPuOi1hOaWme+8jOaLm+mTtuWbvemZheeOr+eQg+W4guWcug==
收藏
行业数据
2025-08-01
原图定位
查看详情
ZG005和AK104在宫颈癌的数据对比(截至20250720)
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
收藏
行业数据
2025-08-01
原图定位
查看详情
2a期临床试验结果显示,特泽利尤单抗在BEC≥150以及FeNO≥25人群中疗效更好
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
收藏
行业数据
2025-07-30
原图定位
查看详情
ZG005:一线晚期宫颈癌中显示优异的有效性及安全性
fCDkuLTluormlrnmoYggfCBaRzAwNSDliYLph48gfCDljJbnlpfoja/niakgfCDotJ3kvJDljZXmipcgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgSeacnyB8IDIwIG1nL2tnIHwg5YyW55aXIHwg6LSd5LyQ5Y2V5oqXIHwKfCBJ5pyfIHwgMTAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAp8IElJ5pyf5omp5bGVIHwgMjAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAp8IElJ5pyf5omp5bGVIHwgMTAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAoK6LWE5paZ5p2l5rqQ77yaQVNDT++8jOWFrOWPuOWFrOWRiu+8jOS4nOWQtOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-07-15
原图定位
查看详情
AK104宫颈癌1L治疗注册临床安全性数据
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
收藏
行业数据
2025-07-08
原图定位
查看详情
维替索妥尤单抗针对复发及转移性宫颈癌国内已提交BLA
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
收藏
行业数据
2025-06-12
原图定位
查看详情
巴托利单抗(HBM9161)作用机制
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
收藏
行业数据
2025-03-03
原图定位
查看详情
巴托利单抗(HBM9161)III期临床结果
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
收藏
行业数据
2025-03-03
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
国内宫颈癌年新发人数达 11 万,潜在市场巨大。而巴替利单抗+泽弗利单抗有望成为首个国产的创新 PD-1+CTLA-4 的产品组合。
行业数据
原图定位
当前图表所属:
医药生物行业跟踪报告:创新药系列研究L1普药化国内IO市场如何演绎-210902(21页).pdf
图表9国产新药申报方案和时间轴对比
图表7KN046单药治疗PD-1经治非小细胞肺癌的初步疗效
图表5AK104宫颈癌数据
图表4AK104安全性对比O+Y
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》